This essential prenatal screening helps assess the risk of genetic conditions, ensuring peace of mind during your pregnancy journey.
Expecting parents can now take advantage of our exclusive Preg Coupon, offering discounted pricing on the Quadruple Marker Test at Diagnopein.
The Quadruple Marker Test measures four critical substances in the blood alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin-A to evaluate the risk of conditions like Down syndrome, Trisomy 18, and neural tube defects.
The Preg Coupon Quadruple Marker Test is a vital prenatal screening that assesses the likelihood of chromosomal abnormalities in the fetus, such as Down syndrome, Edward syndrome, and neural tube defects. Conducted during the second trimester (15–20 weeks of pregnancy), this blood test measures four key markers: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), estriol, and inhibin-A. These markers provide valuable insights into the health of the developing baby, allowing early intervention or further diagnostic testing if necessary. The test is particularly recommended for women over 35, those with a history of pregnancy complications, or those with a family history of genetic disorders.
Choosing Diagnopein for the Preg Coupon Quadruple Marker test offers several advantages. Diagnopein utilizes advanced technology to ensure accurate and reliable test results. The facility employs experienced staff, including trained technicians and specialists, who follow stringent protocols to maintain a clean and hygienic environment. This commitment to cleanliness minimizes the risk of contamination and infection during sample collection. Additionally, Diagnopein is dedicated to delivering precise and timely reports, empowering healthcare providers to make informed patient care decisions.
1. Quadruple Test(2 nd trimester: 14-22.6weeks)
The test helps assess the risk of genetic conditions and structural abnormalities in the fetus, guiding doctors in early detection and management.
Pregnant women, especially those with advanced maternal age, previous high-risk pregnancies, or family history of genetic disorders, are advised to undergo this test.
Yes, it is a simple and safe blood test with no risk to the mother or the fetus.
If the test suggests a high risk, further diagnostic tests like amniocentesis or ultrasounds are recommended for confirmation. Always consult your healthcare provider for guidance.
